Literature DB >> 15582081

Long-term follow-up of indocyanine green-assisted peeling of the retinal internal limiting membrane during vitrectomy surgery for idiopathic macular hole repair.

Andrea P Da Mata1, Scott E Burk, Robert E Foster, Christopher D Riemann, Michael R Petersen, M árcio Bittar Nehemy, James J Augsburger.   

Abstract

OBJECTIVE: To determine the long-term efficacy of indocyanine green (ICG)-assisted retinal internal limiting membrane (ILM) peeling during macular hole repair.
DESIGN: Retrospective, interventional, noncomparative case series. PARTICIPANTS: One hundred twenty-one eyes of 114 patients with stage 2, 3, or 4 idiopathic macular holes that underwent ICG-assisted macular hole repair during the period of August 1999 to January 2003. INTERVENTION: All eyes underwent a pars plana vitrectomy, including peeling of the posterior cortical hyaloid when necessary. Indocyanine green dye (0.5%) was instilled over the macula, and after removal of the ICG, the retinal ILM was peeled. Medium- to long-acting gas tamponade was used in all cases, and all patients were asked to position themselves facedown for 1 to 2 weeks. MAIN OUTCOME MEASURES: Long-term postoperative anatomic results, visual acuity (VA), and complications.
RESULTS: Patients were observed postoperatively for an average of 26 months (range, 12-53). Anatomic closure of the macular hole was achieved in 118 eyes (98%) with a single surgery. Reoperation was successful at closing 2 of the 3 macular holes that did not close initially. One macular hole reopened 16 months after the original surgery, and the patient has not yet undergone further surgery. Visual acuity improved by > or =2 lines in 116 eyes (96%). Mean visual improvement after surgery was 6 lines (range, 0-14), and 96 eyes (79%) achieved a final VA of 20/50 or better. There were no intraoperative or postoperative complications attributed to the use of ICG.
CONCLUSIONS: Long-term follow-up of patients who underwent ICG-assisted ILM peeling for idiopathic macular hole repair demonstrates excellent anatomic and visual results.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15582081     DOI: 10.1016/j.ophtha.2004.05.037

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  24 in total

1.  Let green lead not astray.

Authors:  J Sebag
Journal:  Br J Ophthalmol       Date:  2005-07       Impact factor: 4.638

2.  Retreatment of full-thickness macular hole: predictive value of optical coherence tomography.

Authors:  Jost Hillenkamp; Jürgen Kraus; Carsten Framme; Timothy L Jackson; Johann Roider; Veit-Peter Gabel; Helmut G Sachs
Journal:  Br J Ophthalmol       Date:  2007-05-02       Impact factor: 4.638

3.  Equivalent tamponade by room air as compared with SF(6) after macular hole surgery.

Authors:  Yuhei Hasegawa; Yasuaki Hata; Yasutaka Mochizuki; Ryoichi Arita; Shuhei Kawahara; Takeshi Kita; Yoshihiro Noda; Tatsuro Ishibashi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-06-21       Impact factor: 3.117

4.  Heavy silicone oil (Densiron-68) for the treatment of persistent macular holes: Densiron-68 endotamponade for persistent macular holes.

Authors:  Stanislao Rizzo; Federica Genovesi-Ebert; Andrea Vento; Federica Cresti; Sofia Miniaci; Maria Chiara Romagnoli
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-08-01       Impact factor: 3.117

5.  Quantitative analysis of external limiting membrane, ellipsoid zone and interdigitation zone defects in patients with macular holes.

Authors:  Jacques Ramos Houly; Carlos Eduardo Veloso; Elke Passos; Márcio Bittar Nehemy
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-04-15       Impact factor: 3.117

6.  [Pharmaological vitreolysis with ocriplasmin as a treatment option for symptomatic focal vitreomacular traction with or without macular holes (≤400 μm) compared to tranconjunctival vitrectomy].

Authors:  M Maier; S Abraham; C Frank; C P Lohmann; N Feucht
Journal:  Ophthalmologe       Date:  2017-02       Impact factor: 1.059

7.  [Staining techniques in macular surgery].

Authors:  C Haritoglou; A Kampik
Journal:  Ophthalmologe       Date:  2006-11       Impact factor: 1.059

8.  [Comparison of ILM peeling with and without the use of indocyanine green. Functional results for idiopathic macular hole after pars plana vitrectomy].

Authors:  F Rüfer; A Frimpong-Boateng; A Bunse; J Roider
Journal:  Ophthalmologe       Date:  2007-01       Impact factor: 1.059

9.  An early "reopening" case of idiopathic macular hole; supportive usefulness of fundus autofluorescence.

Authors:  Mitsuru Arima; Masanori Miyazaki; Ri-ichiro Kohno; Yasuaki Hata; Tatsuro Ishibashi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-12-17       Impact factor: 3.117

10.  Effects of Indocyanine green on cultured retinal ganglion cells in-vitro.

Authors:  S Balaiya; Vikram S Brar; Ravi K Murthy; Kv Chalam
Journal:  BMC Res Notes       Date:  2009-11-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.